Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Advertising News.
Press releases published on March 20, 2025
Interventional Pulmonology Market Set to Witness Significant Growth by 2025-2032: Olympus Corporation, Vygon, Karl Storz
EIN Presswire
·
March 20, 2025
Interventional Pulmonology Market is estimated to be valued at US$ 3,535.3 million in 2021 and is expected to exhibit a CAGR of 5.4% by (2021-2028). BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
U.S. Injectable Compounding Pharmacy Market Set to Witness Significant Growth by 2025-2032: Athenex, Inc., SCA Pharma
EIN Presswire
·
March 20, 2025
U.S. Injectable Compounding Pharmacy Market is estimated to be valued at US$ 1,516.3 Mn in 2023 and is expected to exhibit a CAGR of 7.3% by (2023-2030). BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “U.S. …
Mezzanine Finance Market Poised to Reach US$ 420.79 billion by 2034 with a 7.88% CAGR
EIN Presswire
·
March 20, 2025
Mezzanine Finance Market Research Report By, Debt Structure, Industry Application, Capital Type, Investment Strategy, Loan Size, Regional PA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- The global Mezzanine Finance market has witnessed …
Ambulatory Infusion Center Market Set to Witness Significant Growth by 2025-2032: Walgreens Boots Alliance, Healix, LLC
EIN Presswire
·
March 20, 2025
Ambulatory Infusion Center Market is estimated to be valued USD 52.19 Bn in 2025 and is expected to reach USD 107.07 Bn by 2032, exhibiting a CAGR of 10.8%. BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPC Initiating new LINNET Phase 2 study of lorigerlimab in ovarian cancer Advancing multiple novel topoisomerase 1 inhibitor- …
Credit Acceptance Named 2025 Top Workplaces USA Award Winner
GlobeNewswire
·
March 20, 2025
Southfield, Michigan, March 20, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named a 2025 Top Workplaces USA award winner for the fifth consecutive …
NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 Data from the Expansion Study to Support Interaction with FDA and Define Regulatory Strategy for NUC- …
Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights
GlobeNewswire
·
March 20, 2025
– Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission – – Strengthened balance sheet with gross proceeds of …
Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
GlobeNewswire
·
March 20, 2025
Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3 SEACRAFT-2 registrational trial progressing well with Stage 1 randomized data expected in H2 2025 Robust …
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ahead of schedule; interim analysis removed Phase 2a dosing …
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
GlobeNewswire
·
March 20, 2025
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it …
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19 Phase 2b 400-person sentinel cohort Cash, cash equivalents …
Waterstone Financial Declares Regular Quarterly Cash Dividend
GlobeNewswire
·
March 20, 2025
WAUWATOSA, Wis., March 20, 2025 (GLOBE NEWSWIRE) -- On March 20, 2025, the Board of Directors of Waterstone Financial, Inc. (NASDAQ: WSBF) declared a regular quarterly cash dividend of $0.15 per common share. The dividend is payable on May 1, 2025, to …
Editas Medicine Announces Chief Financial Officer Transition
GlobeNewswire
·
March 20, 2025
Erick J. Lucera to Step Down as CFO to pursue another opportunity Senior Vice President of Finance Amy Parison Appointed CFO CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today …
Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
GlobeNewswire
·
March 20, 2025
ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth …
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 20, 2025
TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) Positive …
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
GlobeNewswire
·
March 20, 2025
Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positive initial data from first three subjects with type 1 …
Oxford Lane Capital Corp. Adopts a Share Repurchase Program
GlobeNewswire
·
March 20, 2025
GREENWICH, Conn., March 20, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (the “Company”) today announced …
Sip & Stroll Your Way Through Boerne, TX
GlobeNewswire
·
March 20, 2025
Boerne, TX, March 20, 2025 (GLOBE NEWSWIRE) -- Travelers looking to experience the charm of the Texas Hill Country while sipping their way through some of the region’s best craft breweries and wine bars now have a new way to explore. The Boerne Sip …
Mini Munchkins: Elevating Kids' Celebrations with Unmatched Creativity in the Netherlands
EIN Presswire
·
March 20, 2025
Providing Personalized Event Planning for Families in the Netherlands, with Thoughtfully Designed Themes for Birthdays, Weddings, and Special Gatherings. AMSTERDAM, NOORD HOLLAND, NETHERLANDS, March 20, 2025 /EINPresswire.com/ -- Say goodbye to cookie- …